LENTIPAK Trademark

Trademark Overview

On Wednesday, July 3, 2002, a trademark application was filed for LENTIPAK with the United States Patent and Trademark Office. The USPTO has given the LENTIPAK trademark a serial number of 78141231. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 21, 2013. This trademark is owned by Genetix Pharmaceuticals, Inc.. The LENTIPAK trademark is filed in the Pharmaceutical Products category with the following description:

bioengineered component for a therapeutic material, namely, lentiviral vectors and packaging cell lines used for gene therapy

General Information

Serial Number78141231
Word MarkLENTIPAK
Filing DateWednesday, July 3, 2002
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 21, 2013
Registration Number3171963
Registration DateTuesday, November 14, 2006
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 9, 2003

Trademark Statements

Goods and Servicesbioengineered component for a therapeutic material, namely, lentiviral vectors and packaging cell lines used for gene therapy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 21, 2013
Primary Code005
First Use Anywhere DateTuesday, March 21, 2006
First Use In Commerce DateTuesday, March 21, 2006

Trademark Owner History

Party NameBLUEBIRD BIO, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02139
Party NameGenetix Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameGenetix Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameGenetix Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Friday, June 21, 2013CANCELLED SEC. 8 (6-YR)
Wednesday, November 28, 2012AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, November 14, 2006REGISTERED-PRINCIPAL REGISTER
Wednesday, November 1, 2006ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, October 4, 2006LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, October 3, 2006ASSIGNED TO LIE
Thursday, September 28, 2006ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, August 14, 2006STATEMENT OF USE PROCESSING COMPLETE
Friday, July 14, 2006USE AMENDMENT FILED
Friday, July 14, 2006TEAS STATEMENT OF USE RECEIVED
Thursday, May 25, 2006EXTENSION 5 GRANTED
Thursday, May 25, 2006EXTENSION 5 FILED
Thursday, May 25, 2006TEAS EXTENSION RECEIVED
Friday, December 2, 2005EXTENSION 4 GRANTED
Friday, December 2, 2005EXTENSION 4 FILED
Friday, December 2, 2005TEAS EXTENSION RECEIVED
Tuesday, May 24, 2005EXTENSION 3 GRANTED
Tuesday, May 24, 2005EXTENSION 3 FILED
Tuesday, May 24, 2005TEAS EXTENSION RECEIVED
Monday, November 29, 2004EXTENSION 2 GRANTED
Wednesday, November 17, 2004EXTENSION 2 FILED
Wednesday, November 17, 2004TEAS EXTENSION RECEIVED
Tuesday, June 1, 2004EXTENSION 1 GRANTED
Tuesday, May 25, 2004EXTENSION 1 FILED
Tuesday, May 25, 2004TEAS EXTENSION RECEIVED
Tuesday, December 2, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 9, 2003PUBLISHED FOR OPPOSITION
Wednesday, August 20, 2003NOTICE OF PUBLICATION
Thursday, July 17, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 26, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 11, 2003CASE FILE IN TICRS
Thursday, June 26, 2003PAPER RECEIVED
Monday, June 9, 2003FINAL REFUSAL MAILED
Monday, May 12, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 12, 2003PAPER RECEIVED
Tuesday, November 12, 2002NON-FINAL ACTION MAILED
Sunday, November 10, 2002ASSIGNED TO EXAMINER
Friday, November 8, 2002ASSIGNED TO EXAMINER

Related Keywords

lentipak lines cell used gene therapy packaging vectors therapeutic component material